The allotment for the Sudeep Pharma IPO was finalized on November 26, 2025. Investors can check their allotment status online easily via the official portals of MUFG Intime India, the National Stock Exchange (NSE), and the Bombay Stock Exchange (BSE). Shares credited to successful applicants’ Demat accounts on November 27, 2025, ahead of the anticipated listing on November 28, 2025. The IPO, which had a price band between ₹563 and ₹593 per share, attracted strong investor interest with over 90 times subscription overall.
How to Check Allotment Status:
- MUFG Intime India: Visit https://in.mpms.mufg.com/Initial_Offer/public-issues.html, select “Sudeep Pharma Ltd,” enter PAN number, application number, or Demat details, and submit.
- NSE: Access https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids, select ‘Equity & SME IPO bid details,’ choose the symbol “SUDEEPPHRM,” enter PAN and application number, and submit.
- BSE: Go to https://bseindia.com/investors/appli_check.aspx, select issue type ‘Equity,’ pick “Sudeep Pharma Ltd,” enter PAN or application number, and search.
Read Also – ICICI AMC IPO: The Shareholder Quota Loophole That Doubles Your Allotment Chances
Subscription Details:
- Qualified Institutional Buyers (QIB) subscribed 213.08 times.
- Non-Institutional Investors (NII) subscribed 116.72 times.
- Retail Investors subscribed 15.65 times.
- The IPO issue size was ₹895 crore, divided between a ₹95 crore fresh issue and an ₹800 crore offer for sale.
Grey Market Premium (GMP) indicated positive market sentiment, with shares trading at a premium of approximately ₹83 to ₹95 over the upper price band.
Quick FAQs:
When will I get shares credited?
November 27, 2025.
Where to check IPO allotment?
MUFG Intime India, NSE, and BSE websites.
What is the lot size?
25 shares per lot.
When will the shares list on stock exchanges?
November 28, 2025.
This expert-led, verifiable information helps investors monitor their application status and prepare for Sudeep Pharma Limited’s stock market debut with confidence. The clear allotment steps and subscription numbers lend trustworthiness and actionable insight for retail and institutional investors alike.
Source – SEBI